Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Rodrigo Fonseca

8PUBLICATIONS

64CO-AUTHORS

Predictive and prognostic markersMedical infection agents (incl. prions)Molecular targetsImmunogenetics (incl. genetic immunology)Gene and molecular therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Apr 30, 2026

Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers.

|Jan 02, 2026

Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH).

Marcella Kaddoura, J Erin Wiedmeier-Nutor, Vikas A Gupta

|Feb 05, 2025

Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention.

Rodrigo Fonseca, Yuan Xiao Zhu, Laura A Bruins

|Jul 26, 2024

Assessing outcomes of intravenous insulin therapy in non-intensive care patients.

Mercedes Martinez Gil, Rodrigo Fonseca, Leila K Tehrani

|Feb 08, 2024

Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.

Natthakan Thongon, Feiyang Ma, Natalia Baran

|Sep 28, 2023

Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma.

Seth J Welsh, Benjamin G Barwick, Erin W Meermeier

Pageof 2

Frequent Collaborators

6 joint publications

P Leif Bergsagel

5 joint publications

Rafael Fonseca

4 joint publications

Mariano Arribas

4 joint publications

Marta Chesi

2 joint publications

Joseph R Mikhael

2 joint publications

Craig Reeder

2 joint publications

Esteban Braggio

2 joint publications

Lawrence H Boise

2 joint publications

Yuan Xiao Zhu

1 joint publications

S Chhabra

Frequent Collaborators

6 joint publications

P Leif Bergsagel

5 joint publications

Rafael Fonseca

4 joint publications

Mariano Arribas

4 joint publications

Marta Chesi

Top Related Videos

Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma

Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on : Apr 15, 2022

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on : Dec 09, 2015

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos

Top Related Videos

Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma

Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on : Apr 15, 2022

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on : Dec 09, 2015

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos